NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biora Therapeutics

Biora Therapeutics

Public
San Diego, CaliforniaHealthcarehttps://www.bioratherapeutics.com

Biora Therapeutics is now publicly traded

The data on this page reflects Biora Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jun 19, 2020

Last Round

Bankruptcy

Feb 19, 2025

Total Funding Raised

$512.03M

Company Overview

Biora Therapeutics (NAS: BIOR) is a biotechnology company focused on developing innovative oral biotherapeutics that enhance therapeutic delivery for gastrointestinal diseases and provide needle-free, oral alternatives for systemic biotherapeutics.

Sector

Healthcare

AI Layer

Non-AI

Keywords

smart pillsoral drug deliveryneedle-free deliverydrug delivery platformrobotic pillbiotherapeutics deliveryoral biologicstargeted drug deliverysystemic drug deliveryinflammatory bowel diseaseIBDGI tract deliveryBioJetNaviCapliquid jet injectionulcerative colitistechnology licensing

Biora Therapeutics Comparables

Compare Biora Therapeutics with similar companies based on industry and business-model similarity.

Biora Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Biora Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
BankruptcyFeb 19, 2025
Follow-on OfferingOct 29, 2024
DebtAug 12, 2024
Follow-on OfferingApr 3, 2024
Follow-on OfferingAug 19, 2021
Private Placement
Jun 10, 2021

Biora Therapeutics Investors

Notable investors and investment history

Biora Therapeutics investors
InvestorRounds
H.C. Wainwright & Co.Follow-on Offering
Davidson Kempner Capital ManagementBankruptcy
Wells Fargo Securities, LLCFollow-on Offering, IPO
Athyrium Capital ManagementConvertible Debt, Series A, Series B
Context Capital ManagementBankruptcy
Highbridge Capital ManagementBankruptcy

Biora Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biora Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California
Employee Range47
Year Founded2010
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.